|
- What are Copay Maximizer Programs?
Insurance companies and pharmacy benefit managers (PBMs) use Copay Maximizer Programs (CMPs) to ensure that they get the maximum benefits provided by the drug company These programs spread out the copay assistance over time, decreasing the cost of a patient’s medicine prescription each month
- FDA Drug Competition Action Plan
Through DCAP, FDA is helping remove barriers to generic drug development and market entry, and spur competition that improves consumers’ access to the medicines they need
- Maximizing Patent Protection with FDA Exclusivities
To maximize the benefits of FDA regulatory exclusivities, pharmaceutical companies should follow best practices that include developing a comprehensive understanding of FDA regulations, integrating regulatory exclusivities into patent strategy, and collaborating with regulatory and patent experts
- FDA initiatives to support dose optimization in oncology drug . . .
FDA describes the goals of Project Optimus as follows: • Provide opportunities for and encourage drug developers to meet with FDA Oncology Review Divisions early in their development programs, well before conducting trials intended for registration, to discuss dose-finding and dose optimization
- Makary, Prasad lay out priorities for FDA: Reduced timelines, more AI . . .
FDA Commissioner Marty Makary as he announced FDA's Elsa AI tool in June 2025
- Marketing Your Patented Drug Effectively: Strategies for Maximizing . . .
A pharmaceutical company can only promote its drug for the specific indications, patient populations, and doses that are approved by the FDA and included in the official Prescribing Information, or “label ” Promoting a drug for any other use is known as “off-label” promotion and is strictly prohibited [12]
- A primer on copay accumulators, copay maximizers, and alternative . . .
Insurer or self-insured employer’s plans are increasingly using copay accumulator, copay maximizer, and alternative funding programs (AFPs) to reduce plan spending on high-priced prescriptions
- Drug Channels: Copay Accumulator and Maximizer Update: Adoption Expands . . .
Maximizers allow plan sponsors to extract the full value of a manufacturer’s copay support program By contrast, accumulators allow plans to merely double-dip on the patient's deductible payment Most payers now view copay programs as a piggybank These approaches have altered plans’ traditional approach to—and views of—copay offset programs
|
|
|